Stay updated on IMMU-132 Clinical Trial in Epithelial Cancer

Sign up to get notified when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the IMMU-132 Clinical Trial in Epithelial Cancer page

  1. Check
    yesterday
    Change Detected
    Difference
    0.6%
    Check dated 2025-05-08T07:43:56.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-05-01T04:36:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-23T20:16:23.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed information about the objectives and outcomes of a clinical study involving sacituzumab govitecan-hziy, while adding a list of cancer types and a new version number.
    Difference
    17%
    Check dated 2025-04-16T14:32:41.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T09:19:39.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.5%
    Check dated 2025-04-01T23:22:32.000Z thumbnail image

Stay in the know with updates to IMMU-132 Clinical Trial in Epithelial Cancer

Enter your email address, and we'll notify you when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.